Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of SHR0534 in Healthy Chinese Volunteers
NCT02750553Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jan 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of SHR0534 in type 2 diabetes mellitus (T2DM) (6 arms), sponsored by Hengrui. Primary endpoint: Number of treatment emergent adverse events at Day 31. Started Jan 2015; status: completed.
02
Drugs
SHR0534
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02750553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02750553.